Development of an inhalable contrast agent targeting the respiratory tract mucus layer for pulmonary ultrasonic imaging

James K. Tsuruta, Patrick R. Sears, Meghan E. Rebuli, Andrew S. Weitz, Phillip G. Durham, Phillip W. Clapp, David B. Hill, Lawrence E. Ostrowski, Paul A. Dayton, Melissa C. Caughey · 2024

Read Development of an inhalable contrast agent targeting the respiratory tract mucus layer for pulmonary ultrasonic imaging by James K. Tsuruta, Patrick R. Sears, Meghan E. Rebuli, Andrew S. Weitz, Phillip G. Durham, Phillip W. Clapp, David B. Hill, Lawrence E. Ostrowski, Paul A. Dayton, Melissa C. Caughey (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11609298.txt.

Description

James Tsuruta and co-authors built a breathable contrast agent in 2024 to help ultrasound picture the airways' mucus layer. In cystic fibrosis, mucus clears too slowly, yet current checks are invasive or use radiation. Their bubbles carry a charge that makes them cling to mucus.

In lab tests, the charged bubbles stuck to mucus samples better than standard bubbles and rode along as the mucus moved. They caused no harm or swelling in human airway cells grown in dishes. In mice, the agent lit up the windpipe on ultrasound and caused no ill effects. The authors say the work supports a safe, workable agent for lung ultrasound. Such imaging could one day track mucus clearing without radiation.

Catalog record

CREATORJames K. Tsuruta, Patrick R. Sears, Meghan E. Rebuli, Andrew S. Weitz, Phillip G. Durham, Phillip W. Clapp, David B. Hill, Lawrence E. Ostrowski, Paul A. Dayton, Melissa C. Caughey
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11609298

Browse the full library · About the Tower of Babel